Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET.
The live and archived webcast of the panel will be accessible from the company's website at https://ir.ultragenyx.com/events-presentations.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Contacts – Ultragenyx Pharmaceutical, Inc.InvestorsJoshua Higa ir@ultragenyx.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Cracker Barrel Q3 Restaurant Sales Sizzle, Ups Annual EBITDA Outlook
Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL), on Thursday, reported third-quarter adjusted earnings per share of 58 cents, beating the street view of 32 cents. Quarterly sales of $821.1 million, up 0.5% year over year (Y/Y), missed the analyst consensus estimate of $824.30 million. Restaurant sales accounted for 82.7% of the total revenue, whereas retail accounted for 17.3%. Comparable store restaurant sales increased 1.0% Y/Y, with menu pricing increases of 4.9%. Comparable store retail sales fell 3.8% Y/ EBITDA was $48.1 million, a 0.4% Y/Y increase. Adjusted EBITDA margin remained flat Y/Y at 5.9%. Cracker Barrel President and Chief Executive Officer Julie Masino said "Our third quarter performance exceeded our expectations and represents the fourth consecutive quarter of positive comparable store restaurant sales growth." As of the third quarter-end, cash and cash equivalent stood at $9.8 million. The company's quarterly dividend of 25 cents per share is payable on August 13 to shareholders of record as of July 18, 2025. Cracker Barrel reaffirmed the fiscal year 2025 total revenue outlook of $3.45 billion – $3.50 billion (estimate: $3.47 billion) and raised the adjusted EBITDA outlook to $215 million-$225 million versus the previous outlook of $210 million to $220 million. It expects commodity inflation in the mid 2% range, Hourly wage inflation in the mid 2%, and Capital expenditures of $160 million to $170 million (vs. previous outlook of $160 million to $180 million). Price Action: CBRL shares are trading lower by 3.08% to $55.99 at last check Thursday. Read Next:Photo by Jonathan Weiss via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? CRACKER BARREL OLD (CBRL): Free Stock Analysis Report This article Cracker Barrel Q3 Restaurant Sales Sizzle, Ups Annual EBITDA Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
Cattle Health Market Report 2025 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030: Impacts of Technological Advancements, Disease Outbreaks, Traceability and Food Safety
Cattle Health Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Cattle Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to Cattle Health Market was valued at USD 9.98 Billion in 2024, and is expected to reach USD 16.07 Billion by 2030, rising at a CAGR of 8.22%. Cattle health encompasses the overall well-being and productivity of cattle, which are raised for meat, milk, and other agricultural uses. Maintaining optimal cattle health is crucial for ensuring animal welfare, economic efficiency, and the safety of animal-derived products. The rising global demand for meat and dairy, driven by population growth and increasing income levels, is spurring investment in cattle health solutions. Preventive healthcare practices such as vaccinations, biosecurity protocols, and herd management strategies are essential for mitigating disease risks and enhancing productivity. Advancements in veterinary diagnostics and treatment technologies are further strengthening cattle health management. In addition, regulatory support and growing consumer awareness regarding food safety and sustainable livestock practices are contributing to the market's upward Market Drivers Technological AdvancementsThe cattle health sector is witnessing rapid technological evolution, with smart farming tools playing a key role in monitoring and managing animal well-being. Wearable sensors track vital parameters like temperature, heart rate, and movement, enabling early illness detection. The integration of data analytics allows farmers to interpret large volumes of herd health data, leading to informed decision-making. Remote monitoring using drones and satellite imaging supports pasture management and herd surveillance. Precision livestock farming customizes feeding, medication, and environmental conditions to individual animal needs, enhancing efficiency and outcomes. Blockchain ensures traceability across the cattle lifecycle, boosting transparency and safety. Genetic testing is increasingly used for selecting disease-resistant cattle and improving herd quality, driving innovation in breeding Market Challenges Disease OutbreaksRising global cattle populations have heightened the risk and impact of disease outbreaks, presenting a significant challenge to cattle health management. In 2023, over 65 countries reported widespread cases of diseases such as Foot-and-Mouth Disease, Lumpy Skin Disease, and Bovine Tuberculosis, according to the World Organisation for Animal Health (WOAH). These outbreaks result in major economic setbacks due to reduced productivity, higher veterinary costs, and animal losses from culling mandates. The Food and Agriculture Organization (FAO) reported substantial declines in milk yield and cattle weight in affected regions, with severe implications for profitability. Managing and mitigating the effects of such outbreaks remains a key concern for stakeholders in the cattle Market Trends Traceability and Food SafetyThere is growing consumer demand for transparency and assurance in meat and dairy production, fueling the adoption of traceability systems in cattle farming. These systems offer end-to-end visibility, allowing consumers to access information about cattle origin, farming practices, and processing history. Regulatory authorities have mandated stringent traceability and food safety compliance, compelling producers to adopt robust tracking mechanisms. In cases of contamination or disease, such systems enable swift identification and containment, minimizing wider impacts. Traceability also supports disease surveillance and control, enhancing supply chain reliability. Innovations such as blockchain are being leveraged to secure data integrity, while genetic traceability is gaining momentum for breed verification and quality assurance. Key Attributes: Report Attribute Details No. of Pages 182 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $9.98 Billion Forecasted Market Value (USD) by 2030 $16.07 Billion Compound Annual Growth Rate 8.2% Regions Covered Global Report Scope:Competitive LandscapeCompany Profiles: Detailed analysis of the major companies present in the Global Cattle Health Market. Qiagen LLC Boehringer Ingelheim Thermo Fisher Scientific Elanco Animal Health Idexx Laboratories ID Vet Kyoritsuseiyaku Corporation Merck & Co Inc. Norbrook laboratories Zeotis Inc Cattle Health Market, By Therapeutics: Vaccine Parasiticide Anti-infective Medical Feed Additive Other Therapeutics Cattle Health Market, By Diagnostics: Immunodiagnostic Test Molecular Diagnostics Diagnostic Imaging Clinical Chemistry Other Diagnostics Cattle Health Market, By Region: North America United States Canada Mexico Asia-Pacific China India South Korea Australia Japan Europe Germany France United Kingdom Spain Italy South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Cattle Health Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
$684.29 Mn EConsent In Healthcare Market Trends and Forecasts, 2020-2024 & 2025-2030: Enhanced Patient Engagement Driving Growth, Technological Advancements Gaining Traction
The increasing integration of eConsent with telemedicine and electronic health records (EHRs) is accelerating adoption across healthcare settings. Acknowledging this shift, global institutions such as the World Health Organization (WHO) have highlighted the ethical and legal dimensions of eConsent implementation, reinforcing its growing importance in modern healthcare systems. EConsent In Healthcare Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "EConsent In Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to EConsent In Healthcare Market was valued at USD 351.26 Million in 2024, and is expected to reach USD 684.29 Million by 2030, rising at a CAGR of 11.76% The healthcare sector is undergoing a transformative shift, with electronic informed consent (eConsent) emerging as a vital innovation. This digital solution enhances patient-provider communication while streamlining documentation and administrative workflows. eConsent empowers patients to participate more actively in their care decisions by improving accessibility and comprehension through multimedia tools and digital platforms. Key Market Drivers Enhanced Patient Engagement is Driving the Global EConsent In Healthcare MarketThe growing shift toward digital healthcare delivery is fundamentally reshaping how patients interact with medical providers, and enhanced patient engagement is a primary force behind the expansion of the eConsent market. By incorporating user-friendly multimedia content - such as animations, simplified text, and videos - eConsent platforms help patients better understand procedures, risks, and accessibility improves patient comprehension and supports informed decision-making. These platforms also allow two-way communication, enabling patients to ask questions and clarify concerns at their own convenience, which enhances trust and reduces uncertainty. Integration with electronic health records (EHRs) gives patients greater visibility into their medical history and treatment options. Additionally, the ability to provide consent remotely ensures inclusive access to care, especially for those relying on telemedicine, reinforcing the role of eConsent in supporting modern, patient-centric Market Challenges Regulatory ChallengesNavigating regulatory compliance is one of the most significant hurdles in the global eConsent in healthcare market. Due to healthcare's complex regulatory environment, eConsent platforms must meet diverse standards regarding patient data privacy, security, and documentation across different countries and jurisdictions. Adherence to frameworks such as the General Data Protection Regulation (GDPR) in Europe and the Health Insurance Portability and Accountability Act (HIPAA) in the United States presents both technical and financial challenges. These evolving regulations require eConsent providers to consistently update their systems, which can be both resource-intensive and time-consuming. Ensuring compliance while maintaining functionality and usability across various healthcare systems adds an additional layer of complexity to solution Market Trends Technological AdvancementsAdvancements in technology are significantly reshaping the eConsent landscape. The adoption of electronic signature capabilities has enabled the complete digitalization of consent processes, eliminating paper-based workflows and improving document management. The widespread use of smartphones and mobile applications has further increased the reach of eConsent, allowing patients to review, interact with, and sign forms on-the-go. These platforms can embed interactive tools and multimedia content to enhance patient understanding. In addition, blockchain technology is gaining traction as a solution for securing consent data, offering a transparent and tamper-resistant method of storing sensitive information. These innovations collectively contribute to higher patient confidence, operational efficiency, and regulatory compliance in healthcare settings. Key Attributes: Report Attribute Details No. of Pages 182 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $351.26 Million Forecasted Market Value (USD) by 2030 $684.29 Million Compound Annual Growth Rate 11.7% Regions Covered Global Report Scope: Competitive LandscapeCompany Profiles: Detailed analysis of the major companies present in the Global EConsent In Healthcare Market. Veeva Systems Inc. Wellbeing Software, a Citadel Group Florence Healthcare Inc. Concentric Health Ltd 5thPort, LLC Cloudbyz Inc. Calysta EMR Interlace Health, LLC Thieme Compliance GmbH OpenClinica, LLC eConsent In Healthcare Market, By Platform: Cloud-based Web-based eConsent In Healthcare Market, By Enrollment Type: On-site Remote eConsent In Healthcare Market, By Form Type: General Consent General Consent with Specific Denial(s) General Denial with Specific Consent(s) General Denial eConsent In Healthcare Market, By Region: North America United States Canada Mexico Europe France United Kingdom Italy Germany Spain Asia-Pacific China India Japan Australia South Korea South America Brazil Argentina Colombia Middle East & Africa South Africa Saudi Arabia UAE For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment EConsent In Healthcare Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
